Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **viral mRNA synthesis machinery** refers to the multi-protein enzymatic complexes responsible for generating messenger RNA (mRNA) from viral genomes after infection of a host cell. For RNA viruses, this machinery is often centered around the viral RNA-dependent RNA polymerase (RdRp), which synthesizes complementary RNA strands from the viral RNA genome. The complex typically includes additional viral proteins (such as capping enzymes and helicases) required for mRNA maturation, modification, and stabilization, and in some viruses, it also incorporates select host proteins. This machinery is essential for producing the mRNAs that direct synthesis of viral proteins by hijacking the host cell's translation apparatus[1][4][3][6]. In positive-strand RNA viruses (e.g., SARS-CoV-2, HCV), the incoming viral genome acts directly as mRNA, and RdRp continuously replicates and transcribes viral RNA within specialized replication organelles[1][6]. Many clinically approved and experimental antivirals (e.g., remdesivir) target these polymerase complexes and associated enzymes[6]. Because "viral mRNA synthesis machinery" is a general term encompassing multiple molecular entities (not a single, precisely defined protein or target), the entry is considered problematic for canonical targeting; more specific subunits such as "RNA-dependent RNA polymerase" should be used for structured therapeutic target annotation. Caveat: - The designation "Viral mRNA synthesis machinery" is **not a precise, canonical single-molecule or single-protein target**; it is a functional assembly made up of multiple viral gene products (and sometimes host factors)[1][6]. For structured databases, the main actionable therapeutic target is typically the RNA-dependent RNA polymerase (RdRp), together with viral capping enzymes and associated factors[6]. Thus, entry is flagged as is_incorrect: true per annotation guidelines.
Inhibition of RNA-dependent RNA polymerase (RdRp); Inhibition of viral mRNA capping enzymes; Chain termination during RNA synthesis
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Viral mRNA synthesis machinery.